Warning: The NCBI web site requires JavaScript to function. more...
The dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3G.
Miller JH, Presnyak V, Smith HC.
Retrovirology. 2007 Nov 24;4:81.
Related citations
Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors.
Henriet S, Mercenne G, Bernacchi S, Paillart JC, Marquet R.
Microbiol Mol Biol Rev. 2009 Jun;73(2):211-32. Review.
The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation.
Donahue JP, Vetter ML, Mukhtar NA, D'Aquila RT.
Virology. 2008 Jul 20;377(1):49-53. Epub 2008 May 21.
Inhibition of formula-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication.
Guo F, Cen S, Niu M, Saadatmand J, Kleiman L.
J Virol. 2006 Dec;80(23):11710-22. Epub 2006 Sep 13.
Function analysis of sequences in human APOBEC3G involved in Vif-mediated degradation.
Zhang L, Saadatmand J, Li X, Guo F, Niu M, Jiang J, Kleiman L, Cen S.
Virology. 2008 Jan 5;370(1):113-21. Epub 2007 Oct 4.
Status of APOBEC3G/F in cells and progeny virions modulated by Vif determines HIV-1 infectivity.
Yamashita T, Nomaguchi M, Miyake A, Uchiyama T, Adachi A.
Microbes Infect. 2010 Feb;12(2):166-71. Epub 2009 Nov 26.
Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif.
Mariani R, Chen D, Schröfelbauer B, Navarro F, König R, Bollman B, Münk C, Nymark-McMahon H, Landau NR.
Cell. 2003 Jul 11;114(1):21-31.
Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G.
Schröfelbauer B, Senger T, Manning G, Landau NR.
J Virol. 2006 Jun;80(12):5984-91.
APOBEC3G-UBA2 fusion as a potential strategy for stable expression of APOBEC3G and inhibition of HIV-1 replication.
Li L, Liang D, Li JY, Zhao RY.
Retrovirology. 2008 Aug 4;5:72.
A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
Xu H, Svarovskaia ES, Barr R, Zhang Y, Khan MA, Strebel K, Pathak VK.
Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5652-7. Epub 2004 Mar 30.
Nuclear Exclusion of the HIV-1 host defense factor APOBEC3G requires a novel cytoplasmic retention signal and is not dependent on RNA binding.
Bennett RP, Presnyak V, Wedekind JE, Smith HC.
J Biol Chem. 2008 Mar 21;283(12):7320-7. Epub 2007 Dec 28.
Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs.
Svarovskaia ES, Xu H, Mbisa JL, Barr R, Gorelick RJ, Ono A, Freed EO, Hu WS, Pathak VK.
J Biol Chem. 2004 Aug 20;279(34):35822-8. Epub 2004 Jun 20.
The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.
Sheehy AM, Gaddis NC, Malim MH.
Nat Med. 2003 Nov;9(11):1404-7. Epub 2003 Oct 5.
The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity.
Kao S, Khan MA, Miyagi E, Plishka R, Buckler-White A, Strebel K.
J Virol. 2003 Nov;77(21):11398-407.
Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G.
Liu B, Yu X, Luo K, Yu Y, Yu XF.
J Virol. 2004 Feb;78(4):2072-81.
HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability.
Stopak K, de Noronha C, Yonemoto W, Greene WC.
Mol Cell. 2003 Sep;12(3):591-601.
Vpr14-88-Apobec3G fusion protein is efficiently incorporated into Vif-positive HIV-1 particles and inhibits viral infection.
Ao Z, Yu Z, Wang L, Zheng Y, Yao X.
PLoS One. 2008 Apr 16;3(4):e1995.
The viral infectivity factor (Vif) of HIV-1 unveiled.
Rose KM, Marin M, Kozak SL, Kabat D.
Trends Mol Med. 2004 Jun;10(6):291-7. Review.
Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G.
Cen S, Peng ZG, Li XY, Li ZR, Ma J, Wang YM, Fan B, You XF, Wang YP, Liu F, Shao RG, Zhao LX, Yu L, Jiang JD.
J Biol Chem. 2010 May 28;285(22):16546-52. Epub 2010 Apr 2.
Functional analysis of the two cytidine deaminase domains in APOBEC3G.
Li X, Ma J, Zhang Q, Zhou J, Yin X, Zhai C, You X, Yu L, Guo F, Zhao L, Li Z, Zeng Y, Cen S.
Virology. 2011 Jun 5;414(2):130-6. Epub 2011 Apr 13.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on